[go: up one dir, main page]

WO2010039145A1 - Method and concentrate for enhancing the efficacy of zinc pyrithione in personal care products - Google Patents

Method and concentrate for enhancing the efficacy of zinc pyrithione in personal care products Download PDF

Info

Publication number
WO2010039145A1
WO2010039145A1 PCT/US2008/078665 US2008078665W WO2010039145A1 WO 2010039145 A1 WO2010039145 A1 WO 2010039145A1 US 2008078665 W US2008078665 W US 2008078665W WO 2010039145 A1 WO2010039145 A1 WO 2010039145A1
Authority
WO
WIPO (PCT)
Prior art keywords
zpt
personal care
particle size
zinc pyrithione
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/078665
Other languages
French (fr)
Inventor
Kolazi S. Narayanan
Domingo Jon
Raymond Rigoletto
Roger L. Mcmullen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ISP Investments LLC
Original Assignee
ISP Investments LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ISP Investments LLC filed Critical ISP Investments LLC
Priority to PCT/US2008/078665 priority Critical patent/WO2010039145A1/en
Publication of WO2010039145A1 publication Critical patent/WO2010039145A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4933Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having sulfur as an exocyclic substituent, e.g. pyridinethione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8164Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical, and containing at least one other carboxyl radical in the molecule, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers, e.g. poly (methyl vinyl ether-co-maleic anhydride)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8176Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/91Graft copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin

Definitions

  • the present invention relates to the fungicide zinc pyrithione (ZPT) and more particularly, to a method and composition for increasing dispersabiiity and the deposition of particulate ZPT on the scalp for personal care products such as anti- dandruff shampoos, without adversely affecting its bioavailability, and while maintaining the cosmetic benefits of the shampoo application.
  • ZPT fungicide zinc pyrithione
  • ZPT zinc pyrithione
  • a suitable material for this purpose is zinc pyrithione (ZPT) which is a chelate of zinc ions and pyrithione.
  • ZPT particles tend to agglomerate in use which decreases their dispersabiiity, i.e., reduces their deposition and/or retention on the scalp during showering.
  • ZPT should deposit on the scalp itself to enhance its bioavailability rather than on the hair.
  • ZPT zinc pyrithione
  • a method for increasing the deposition of zinc pyrithione (ZPT) present in a personal care product without reducing its bioavailability and while maintaining the efficacy of such product comprises including in said product a polymer selected from the group consisting of: a) a powder blend of the partially neutralized alkyl ester of poly (methyl vinyl ether maieic acid) and polyvinyl pyrrolidone; b) an aqueous suspension of a water insoluble alkylated grafted vinyl pyrrolidone graft copolymer having a submicron particle size; and c) a unseed oil-modified dicarboxylic acid half-ester of maieic acid.
  • ZPT zinc pyrithione
  • this invention provides a concentrate comprising zinc pyrithione, at least one of the above-described polymers and a carrier.
  • a personal care product comprising zinc pyrithione, at least one of the above described polymers and optionally one or more personal care ingredients.
  • ZPT zinc pyrithione
  • specific polymers i.e., a polymer selected from a powder blend of the partially neutralized monobutyl ester of poly (methyl vinyl ether maieic acid) and polyvinyl pyrrolidone; an aqueous suspension of a water insoluble Ci 6 alkylated grafted vinyl pyrrolidone graft copolymer having a submicron particle size; and a linseed oil-modified dicarboxylic acid half-ester of maleic acid
  • the invention can also be practiced in conjunction with other actives besides zinc pyrithione, such as, for example, zinc/magnesium, copper, cadmium, barium, bismuth and zirconium pyrithiones, coai tar, salicylic acid, selenium sulfide, sulfur, and with other polymers
  • the zinc pyrithione can be present in a particle size of about 0.5- 5 ⁇ , preferably 0.8- 4 ⁇ , and most preferably 1-3 ⁇ .
  • a preferred polymer additive for ZPT dispersing is the sodium salt of alkyivinylether maleic acid half-ester copolymer (EasySperse ® ) (ISP) and polyvinyl pyrrolidone (PVP K-30), most preferably in a weight ratio of about 1 :1 to 1 :4, sold by ISP as EasySperse ® P-20.
  • EasySperse ® is described in U.S. Patent No. 6,158,803, the disclosure of which is hereby incorporated by reference in its entirety.
  • a powder blend of the partially neutralized monobutyl ester of poly (methyl vinyl ether maleic acid) and polyvinyl pyrro ⁇ done is employed.
  • Another suitable polymer to disperse or retain ZPT is milk of Ganex (ISP), which is an aqueous suspension of Ganex ® 216 (ISP) 1 a water-insoluble alkyl grafted polyvinyl pyrrolidone graft copolymer having a particle size at the submicron level.
  • ISP aqueous suspension of Ganex ® 216
  • M ⁇ k of Ganex is described in U.S. Patent No. 6,624,242, the disclosure of which is hereby incorporated by reference in its entirety.
  • an aqueous suspension of a water-insoiuble C- I ⁇ alkyl grafted polyvinyl pyrrolidone graft copolymer having a particle size at the submicron level is described in U.S. Patent No. 6,624,242, the disclosure of which is hereby incorporated by reference in its entirety.
  • Still another useful polymer herein is a partially netralized linseed oil- modified dicarboxylic acid half-ester of maleic acid.
  • This material is commercially available as a liquid from Ashland Chemical under the tradename Bomol 4N. This product is neutralized with 2-aminopropanol to a neutral pH.
  • the concentrate according to this invention includes ZPT, at least one of the above-described polymers and a suitable carrier.
  • a preferred suitable carrier is water.
  • the ZPT can be present in the concentrate in an amount of 1-55, preferably 5-50 and most preferably 10-40% by weight.
  • the concentrate can contain conventional adjuvants, e.g., suspending agents, defoamers and thickening agents, known in the art in amounts up to about 10% by weight.
  • the polymer can be present in the concentrate generally in an amount of
  • the polymer preferably can be present in an amount of about 0.1-10, more preferably 0.5-5, and most preferably 1-4% by weight.
  • the polymer preferably can be present in an amount of about 2-15, more preferably 3-12, and most preferably 4-10% by weight.
  • the polymer preferably can be present in an amount of about 0.1- 15, more preferably 0.5-12, and most preferably 1-10% by weight. The optimum amount of polymer present depends on, e.g., the polymer and active selected, the ZPT particle size, etc. and can readily be determined by one of ordinary skill in the art.
  • Personal care products according to this invention feature ZPT and at least one of the above-described polymers.
  • the ZPT can be present in an amount of 0.001-10, preferably 0.01-5 and more preferably 0.1-2% by weight.
  • anti-dandruff applications e.g., anti-dandruff shampoos
  • the polymer can be added to the personal care product by known techniques.
  • the polymer can be added directly to the ZPT containing personal care product, in a preferred embodiment, the concentrate of this invention is incorporated into the process for manufacturing the personal care product.
  • the following examples further illustrate the invention.
  • test shampoo matrix used to incorporate the various poiymeric dispersants with ZPT.
  • a second test shampoo matrix evaluated was a commercial shampoo matrix.
  • these formulations are merely representative and it is understood that the invention can be practiced, e.g., with other shampoos and personal care compositions containing various surfactants, blends of surfactants and adjuvants known in the art. See, for example, U. S. Patent No. 7,026,308, the disclosure of which is hereby incorporated by reference in its entirety.
  • Shampoo matrices containing bio-active materials and polymeric additives were prepared. Polymeric additives were first incorporated into commercial ZPT dispersions. The fortified commercial ZPT dispersions were then added and homogenized with the shampoo matrices. 1.83% Zinc pyrithione and 0.19% Ganex 216 fine suspension in water (10% solid) in shampoo base
  • 1.83% Zinc Pyrithione, 0.19% Ganex emuision and 89.83% shampoo base was formulated as follows: a premix oil was prepared by mixing 6.08 g zinc pyrithione (Arch 30% suspension concentrate) with 0.34% Ganex 216 fine suspension in water (pre-dispersed with EasySperse (ISP) in water) in a 10 ml vial. The pre-mixed sample was shaken vigorously and it was allowed to mix in a rotary wheel for four hours. 3.5 g of a shampoo matrix was weighed and added to a 50 ml container. 3.38 g of water and 45.03 g of a shampoo base were added to the container. This formulated sample was shaken vigorously and it was allowed to mix in a rotary wheel overnight. A homogeneous cloudy suspension was formed that separated over a weekend but was re-dispersible with moderate shaking.
  • Zinc pyrithione in 89.73% shampoo base (containing water) made up to 100% with water was formulated as follows: 3.35 g of ⁇ 55% zinc pyrithione concentrate (Arch chemicals), was weighed and added to a 50 ml container. 3.47 g of water and 45.01 g of shampoo base were also added to the container. This formulated sample was shaken vigorously and it was allowed to mix in a rotary wheel overnight. A homogeneous cloudy suspension was formed that separated over the weekend but was re-dispersible with moderate shaking.
  • Table 1 summarizes compositions prepared for evaluating dispersion stability and effects of improvement in accordance with this invention.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a method for increasing the deposition of zinc pyrithione present in a personal care product without reducing its bioavailability and while maintaining the efficacy of the product. The method comprises, including with the zinc pyrithione, a polymer selected from a powder blend of an alkyl ester of poly (methyl vinyl ether maleic acid) partially neutralized and polyvinyl pyrrolidone; an aqueous suspension of a water insoluble alkylated grafted vinyl pyrrolidone graft copolymer having a submicron particle size; and a partially neutralized linseed oil-modified dicarboxyic acid half-ester of maleic acid. The present invention further relates to concentrates and personal care products featuring zinc pyrithione and at least one of the above-described polymers.

Description

METHOD AND CONCENTRATE FOR ENHANCING THE EFFICACY OF ZINC PYRITHIONE IN PERSONAL CARE PRODUCTS
FIELD OF THE INVENTION
[0001] The present invention relates to the fungicide zinc pyrithione (ZPT) and more particularly, to a method and composition for increasing dispersabiiity and the deposition of particulate ZPT on the scalp for personal care products such as anti- dandruff shampoos, without adversely affecting its bioavailability, and while maintaining the cosmetic benefits of the shampoo application.
BACKGROUND OF THE INVENTION
[0002] Personal care products such as shampoos often contain a fungicide in small amounts to prevent dandruff from forming and to reduce or preclude the possibility of any fungus attack. A suitable material for this purpose is zinc pyrithione (ZPT) which is a chelate of zinc ions and pyrithione. However, ZPT particles tend to agglomerate in use which decreases their dispersabiiity, i.e., reduces their deposition and/or retention on the scalp during showering.
[0003] Furthermore, it is desired that ZPT should deposit on the scalp itself to enhance its bioavailability rather than on the hair. These and other attributes of ZPT are known in the art and are the subject of considerable research and development to provide improved ZPT-containing cosmetic products.
[0004] Accordingly, it is an object of this invention to provide a new and improved zinc pyrithione composition for use as an additive in personal care products. A particular object is to provide such compositions which will improve the deposition/retention of zinc pyrithione from shampoo products on the scalp rather than the hair, without affecting its bioavailability and while maintaining the cosmetic benefits of the shampoo application. SUMMARY OF THE INVENTION
[0005] We have discovered that the deposition of zinc pyrithione (ZPT) present in a personal care product on the scalp can be significantly enhanced without reducing its bioavailability and while maintaining the efficacy of the product by including in the product a polymer selected from a powder blend of the partially neutralized monobutyl ester of poly (methyl vinyl ether maieic acid) and polyvinyl pyrrolidone; an aqueous suspension of a water insoluble Ci6 alkylated grafted vinyl pyrrolidone graft copolymer having a submicron particle size; and a linseed oil-modified dicarboxylic acid half-ester of maieic acid.
[0006] More specifically, in accordance with this invention, there is provided a method for increasing the deposition of zinc pyrithione (ZPT) present in a personal care product without reducing its bioavailability and while maintaining the efficacy of such product, which comprises including in said product a polymer selected from the group consisting of: a) a powder blend of the partially neutralized alkyl ester of poly (methyl vinyl ether maieic acid) and polyvinyl pyrrolidone; b) an aqueous suspension of a water insoluble alkylated grafted vinyl pyrrolidone graft copolymer having a submicron particle size; and c) a unseed oil-modified dicarboxylic acid half-ester of maieic acid.
[0007] In another aspect, this invention provides a concentrate comprising zinc pyrithione, at least one of the above-described polymers and a carrier.
[0008] In a further embodiment, there is provided a personal care product comprising zinc pyrithione, at least one of the above described polymers and optionally one or more personal care ingredients.
DETAILED DESCRIPTION OF THE INVENTION
[0009] While the invention is described hereinafter with respect to preferred embodiments thereof, e.g., the deposition of zinc pyrithione (ZPT) in combination with specific polymers, i.e., a polymer selected from a powder blend of the partially neutralized monobutyl ester of poly (methyl vinyl ether maieic acid) and polyvinyl pyrrolidone; an aqueous suspension of a water insoluble Ci6 alkylated grafted vinyl pyrrolidone graft copolymer having a submicron particle size; and a linseed oil-modified dicarboxylic acid half-ester of maleic acid, the invention can also be practiced in conjunction with other actives besides zinc pyrithione, such as, for example, zinc/magnesium, copper, cadmium, barium, bismuth and zirconium pyrithiones, coai tar, salicylic acid, selenium sulfide, sulfur, and with other polymers, such as, for example, film forming anionic polymeric dispersants containing a significant number of negative charges and at least one hydrophobic anchoring group for every ten repeat units, either as a single polymeric moiety or combinations of two or more polymers.
[0010] For personal care applications, e.g., anti-dandruff applications, the zinc pyrithione can be present in a particle size of about 0.5- 5 μ, preferably 0.8- 4 μ, and most preferably 1-3 μ.
[0011] A preferred polymer additive for ZPT dispersing is the sodium salt of alkyivinylether maleic acid half-ester copolymer (EasySperse®) (ISP) and polyvinyl pyrrolidone (PVP K-30), most preferably in a weight ratio of about 1 :1 to 1 :4, sold by ISP as EasySperse® P-20. EasySperse® is described in U.S. Patent No. 6,158,803, the disclosure of which is hereby incorporated by reference in its entirety. In a particularly preferred embodiment, a powder blend of the partially neutralized monobutyl ester of poly (methyl vinyl ether maleic acid) and polyvinyl pyrroϋdone is employed.
[0012] Another suitable polymer to disperse or retain ZPT is milk of Ganex (ISP), which is an aqueous suspension of Ganex® 216 (ISP)1 a water-insoluble alkyl grafted polyvinyl pyrrolidone graft copolymer having a particle size at the submicron level. Mϋk of Ganex is described in U.S. Patent No. 6,624,242, the disclosure of which is hereby incorporated by reference in its entirety. In a preferred embodiment, an aqueous suspension of a water-insoiuble C-IΘ alkyl grafted polyvinyl pyrrolidone graft copolymer having a particle size at the submicron level.
[0013] Still another useful polymer herein is a partially netralized linseed oil- modified dicarboxylic acid half-ester of maleic acid. This material is commercially available as a liquid from Ashland Chemical under the tradename Bomol 4N. This product is neutralized with 2-aminopropanol to a neutral pH.
[0014] Mixtures of the above polymers also may be used. The concentrate according to this invention includes ZPT, at least one of the above-described polymers and a suitable carrier. A preferred suitable carrier is water. The ZPT can be present in the concentrate in an amount of 1-55, preferably 5-50 and most preferably 10-40% by weight. The concentrate can contain conventional adjuvants, e.g., suspending agents, defoamers and thickening agents, known in the art in amounts up to about 10% by weight.
[0015] The polymer can be present in the concentrate generally in an amount of
0.1 to about 15% by weight. In the case of polymer a) the polymer preferably can be present in an amount of about 0.1-10, more preferably 0.5-5, and most preferably 1-4% by weight. In the case of polymer b) the polymer preferably can be present in an amount of about 2-15, more preferably 3-12, and most preferably 4-10% by weight. In the case of polymer c) the polymer preferably can be present in an amount of about 0.1- 15, more preferably 0.5-12, and most preferably 1-10% by weight. The optimum amount of polymer present depends on, e.g., the polymer and active selected, the ZPT particle size, etc. and can readily be determined by one of ordinary skill in the art.
[0016] Personal care products according to this invention feature ZPT and at least one of the above-described polymers. In the end use personal care product, the ZPT can be present in an amount of 0.001-10, preferably 0.01-5 and more preferably 0.1-2% by weight. For anti-dandruff applications, e.g., anti-dandruff shampoos, it is preferred that the ZPT be present in an amount of 0.1-2% by weight.
[0017] The polymer can be added to the personal care product by known techniques. For example, the polymer can be added directly to the ZPT containing personal care product, in a preferred embodiment, the concentrate of this invention is incorporated into the process for manufacturing the personal care product. The following examples further illustrate the invention. EXAMPLES
[0018] Described below is a test shampoo matrix used to incorporate the various poiymeric dispersants with ZPT. A second test shampoo matrix evaluated was a commercial shampoo matrix. However, these formulations are merely representative and it is understood that the invention can be practiced, e.g., with other shampoos and personal care compositions containing various surfactants, blends of surfactants and adjuvants known in the art. See, for example, U. S. Patent No. 7,026,308, the disclosure of which is hereby incorporated by reference in its entirety.
Test Shampoo Matrix
Order of Wt in 90
Ingredient addition parts
1 Deionized water 43.61
2 Cocamidopropyl Betaine (Miratene CB) 8.00
3 Sodium Laureth Sulfate (Rodapex ES-2) 17.50
4 Ammonium Lauryl Sulfate (Rodapon L-22) 17.50
5 Ceraphyl 41 1.00
6 Liquid Germaii Plus 0.30
7 Citric Acid (25% aq. sol'n) 0.09
8 Sodium Chloride (25% aq. sol'n) 2.00
Sodium Hydroxide (50% aq. sol'n) To pH 5.91
Total 90.00
Procedure:
1. Weigh water into a suitable container, start mixing.
2. Add ingredients one at a time in order indicated above.
3. Mix well in between each addition.
[0019] Shampoo matrices containing bio-active materials and polymeric additives were prepared. Polymeric additives were first incorporated into commercial ZPT dispersions. The fortified commercial ZPT dispersions were then added and homogenized with the shampoo matrices. 1.83% Zinc pyrithione and 0.19% Ganex 216 fine suspension in water (10% solid) in shampoo base
[0020] 1.83% Zinc Pyrithione, 0.19% Ganex emuision and 89.83% shampoo base was formulated as follows: a premix oil was prepared by mixing 6.08 g zinc pyrithione (Arch 30% suspension concentrate) with 0.34% Ganex 216 fine suspension in water (pre-dispersed with EasySperse (ISP) in water) in a 10 ml vial. The pre-mixed sample was shaken vigorously and it was allowed to mix in a rotary wheel for four hours. 3.5 g of a shampoo matrix was weighed and added to a 50 ml container. 3.38 g of water and 45.03 g of a shampoo base were added to the container. This formulated sample was shaken vigorously and it was allowed to mix in a rotary wheel overnight. A homogeneous cloudy suspension was formed that separated over a weekend but was re-dispersible with moderate shaking.
1.83% Zinc pyrithione in shampoo base
[0021] 1.8% Zinc pyrithione in 89.73% shampoo base (containing water) made up to 100% with water was formulated as follows: 3.35 g of ~ 55% zinc pyrithione concentrate (Arch chemicals), was weighed and added to a 50 ml container. 3.47 g of water and 45.01 g of shampoo base were also added to the container. This formulated sample was shaken vigorously and it was allowed to mix in a rotary wheel overnight. A homogeneous cloudy suspension was formed that separated over the weekend but was re-dispersible with moderate shaking.
[0022] Table 1 summarizes compositions prepared for evaluating dispersion stability and effects of improvement in accordance with this invention.
Table 1 - Addition of polymers to ZPT concentrate
Polymer ZPT Concentrate (30% a.i.)
No Polymer (control) 0% 100%
Milk of Ganex 5% 95%
Milk of Ganex 10% 90%
Bomol 4N 5% 95%
Bomol 4N 10% 90%
EasySperse P20 2% 98% [0023] Six samples containing 12 g of the mixed poiymer/ZPT concentrate were prepared by mixing polymers and ZPT concentrate in the above percentage in a 4 dram vial. Each sample was initiaily shaken manually and left in a rotary wheel overnight. Samples were tested for phase stability.
[0024] In vitro simulated test using animal skin substrate was used to evaluate deposited ZPT from ZPT polymer concentrates and the various shampoos evaluated in accordance with this invention. Concentrates and shampoos were applied to the skin which is loaded with hair bundle, lathered and washed. The deposited active ZPT was extracted and determined analytically by techniques known in the art.
[0025] It was found that the addition of polymers a, b and c to the shampoo matrices evaluated resulted in an increase in dispersability and a considerable reduction in agglomeration of ZPT particles. Polymers a and b were found to provide enhanced deposition amounts, i.e., increased deposited zinc concentration on skin, compared to the control. In the case of polymers a and b in the commercial shampoo matrix, enhanced deposition amounts, i.e., from about 50 to greater than a 100% increased deposited zinc concentration on skin, were measured compared to the control. Moreover, the addition of polymers a, b and c into the shampoo matrices did not adversely affect important hair attributes such as wet combability, wet feel, dry combability, dry feel, shine or static of the shampoo compositions.
[0026] While the invention has been described with particular reference to certain embodiments thereof, it will be understood that changes and modifications may be made which are within the skill of the art.

Claims

CLAIMSWhat is claimed:
1. A method for increasing the deposition of zinc pyrithione (ZPT) present in a personal care product without reducing its bioavailability and while maintaining the efficacy of said product, which comprises inciuding in said product a polymer selected from the group consisting of:
a) a powder blend of the partially neutralized alky! ester of poly (methyl vinyl ether maleic acid) and polyvinyl pyrrolidone;
b) an aqueous suspension of a water insoluble alkylated grafted vinyl pyrrolidone graft copolymer having a submicron particle size; and
c) a partially neutralized linseed oil-modified dicarboxylic acid half- ester of maleic acid.
2. The method of claim 1 wherein said ZPT has a particle size of 0,5-5 μ.
3. The method of claim 1 wherein said ZPT has a particle size of 0.8-4 μ.
4. A concentrate comprising zinc pyrithione, a polymer selected from the group consisting of:
a) a powder blend of the partially neutralized ester of poly (methyl vinyl ether maleic acid) and polyvinyl pyrrolidone; or
b) an aqueous suspension of a water insoluble alkylated grafted vinyl pyrrolidone graft copolymer having a submicron particle size; or
c) a partially neutralized linseed oil-modified dicarboxylic acid half- ester of maleic acid; and
d) a carrier.
5. The concentrate of claim 4 wherein said carrier is water.
6. The concentrate of claim 4 wherein said ZPT has a particle size of 0.5-5μ.
7. The concentrate of claim 4 wherein said polymer is present in an amount of 0.1 -15% by weight.
8. A personal care product comprising ZPT and a polymer selected from the group consisting of;
a) a powder blend of the partially neutralized ester of poly (methyl vinyl ether maleic acid) and polyvinyl pyrrolidone; or
b) an aqueous suspension of a water insoluble alkylated grafted vinyl pyrrolidone graft copolymer having a submicron particle size; or
c) a partially neutralized linseed oil-modified dicarboxylic acid half-ester of maleic acid.
9. The persona! care product of claim 8 wherein said ZPT has a particle size of 0.5-5μ.
10. The personal care product of claim 8 wherein said ZPT is present in an amount of 0.001-10% by weight.
11. The personal care product of claim 9 that is an anti-dandruff shampoo.
12. The personal care product of claim 11 wherein said ZPT is present in an amount of 0.01-2% by weight.
PCT/US2008/078665 2008-10-03 2008-10-03 Method and concentrate for enhancing the efficacy of zinc pyrithione in personal care products Ceased WO2010039145A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/US2008/078665 WO2010039145A1 (en) 2008-10-03 2008-10-03 Method and concentrate for enhancing the efficacy of zinc pyrithione in personal care products

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/078665 WO2010039145A1 (en) 2008-10-03 2008-10-03 Method and concentrate for enhancing the efficacy of zinc pyrithione in personal care products

Publications (1)

Publication Number Publication Date
WO2010039145A1 true WO2010039145A1 (en) 2010-04-08

Family

ID=42073755

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/078665 Ceased WO2010039145A1 (en) 2008-10-03 2008-10-03 Method and concentrate for enhancing the efficacy of zinc pyrithione in personal care products

Country Status (1)

Country Link
WO (1) WO2010039145A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014082846A1 (en) * 2012-11-29 2014-06-05 Unilever Plc Hair care composition
CN104812365A (en) * 2012-11-29 2015-07-29 荷兰联合利华有限公司 Hair care composition
US9556405B2 (en) 2012-11-29 2017-01-31 Conopco, Inc. Polymer structured aqueous detergent compositions
US10166173B2 (en) 2014-12-02 2019-01-01 Dow Global Technologies Llc Polyurethane microparticles coated with a zinc salt and methods for the preparation thereof
US20190091115A1 (en) * 2017-09-28 2019-03-28 The Procter & Gamble Company Conditioner compositions with polyacrylate microcapsules having improved long-lasting odor benefit

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6335312B1 (en) * 1997-10-14 2002-01-01 The Procter & Gamble Company Personal cleansing compositions comprising mid-chain branched surfactants
US20020011584A1 (en) * 2000-02-14 2002-01-31 Hirotaka Uchiyama Stable, aqueous compositions for treating surfaces, especially fabrics

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6335312B1 (en) * 1997-10-14 2002-01-01 The Procter & Gamble Company Personal cleansing compositions comprising mid-chain branched surfactants
US20020011584A1 (en) * 2000-02-14 2002-01-31 Hirotaka Uchiyama Stable, aqueous compositions for treating surfaces, especially fabrics

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014082846A1 (en) * 2012-11-29 2014-06-05 Unilever Plc Hair care composition
CN104812365A (en) * 2012-11-29 2015-07-29 荷兰联合利华有限公司 Hair care composition
JP2016500120A (en) * 2012-11-29 2016-01-07 ユニリーバー・ナームローゼ・ベンノートシヤープ Hair care composition
US9556405B2 (en) 2012-11-29 2017-01-31 Conopco, Inc. Polymer structured aqueous detergent compositions
US10166173B2 (en) 2014-12-02 2019-01-01 Dow Global Technologies Llc Polyurethane microparticles coated with a zinc salt and methods for the preparation thereof
US20190091115A1 (en) * 2017-09-28 2019-03-28 The Procter & Gamble Company Conditioner compositions with polyacrylate microcapsules having improved long-lasting odor benefit
EP3461470A1 (en) * 2017-09-28 2019-04-03 The Procter & Gamble Company Conditioner compositions with polyacrylate microcapsules having improved long-lasting odor benefit
WO2019067661A1 (en) * 2017-09-28 2019-04-04 The Procter & Gamble Company Conditioner compositions with polyacrylate microcapsules having improved long-lasting odor benefit
CN111148501A (en) * 2017-09-28 2020-05-12 宝洁公司 Polyacrylate microencapsulated conditioner compositions with improved long-lasting odor benefits
JP2020533361A (en) * 2017-09-28 2020-11-19 ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company Conditioner composition containing polyacrylate microcapsules with improved long lasting scent effect
JP7007464B2 (en) 2017-09-28 2022-01-24 ザ プロクター アンド ギャンブル カンパニー Conditioner composition containing polyacrylate microcapsules with improved long lasting scent effect

Similar Documents

Publication Publication Date Title
CN101112349B (en) Shampoo composition provided with anti-dandruff and opsonize efficacy
DE3910170B4 (en) Bacterial desorption composition
CA2318337C (en) Use in cosmetic compositions of amphoteric surface-active agents for precipitating cationic polymers in the diluted state
CN101690697B (en) Anti-dandruff shampoo composition
WO2010039145A1 (en) Method and concentrate for enhancing the efficacy of zinc pyrithione in personal care products
WO1994006409A1 (en) Hair conditioning shampoo
WO1996016546A1 (en) Germicidal detergent-iodine compositions including polyvinyl pyrrolidone and compatible nonionic surfactant complexors
CZ167699A3 (en) Body or hair cleansing composition containing fungicidal agent and phospholipid as well as process for preparing such composition
CZ293585B6 (en) Body and or hair cleansing composition and process for preparing such composition
CN102258037B (en) Containing the bactericidal composition of benziothiazolinone and Tebuconazole
TW575399B (en) Fungicide composition
WO2012135265A2 (en) Suncare compositions and methods
US11376209B2 (en) Antidandruff composition and method of use
KR100361029B1 (en) Hair cosmetics containing zinc pyrithione-polymeric quaternary ammonium salt complex
CN110114051B (en) Antimicrobial composition
JPH01283201A (en) Stable aqueous suspension pesticide composition
KR100425983B1 (en) The stabilized silver colloid composition, the preparing method of the stabilized silver colloid composition, and the cosmetic composition containing the aforementioned composition
EP4025334A1 (en) Microcapsule and hair care composition
US20060135472A1 (en) Use of water-soluble polymers to improve stability of diiodomethyl-para-tolylsulfone in complex matrices
JPS584572B2 (en) Aqueous surfactant composition
CN111050734B (en) Antimicrobial compositions
CN113663082A (en) Acetylcysteine-stabilized gold nanoclusters for acute kidney injury and their preparation methods and applications
JPH01153644A (en) Germicidal composition
CN118020764A (en) Ivermectin photolysis-resistant preparation
WO2019063222A1 (en) An antimicrobial composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08824443

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 27/07/2011)

122 Ep: pct application non-entry in european phase

Ref document number: 08824443

Country of ref document: EP

Kind code of ref document: A1